NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

透析市場成長機會·成長預測 (2021-2028年):類型·產品&服務 ·終端用戶·各地區

Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Product & Service (Equipment, Consumables, Drugs, and Services), and End User (In-center Dialysis and Home Dialysis): Global Opportunity Analysis and Industry Forecast, 2021-2028

出版商 Allied Market Research 商品編碼 1017283
出版日期 內容資訊 英文 307 Pages
商品交期: 2-3個工作天內
價格
透析市場成長機會·成長預測 (2021-2028年):類型·產品&服務 ·終端用戶·各地區 Dialysis Market by Type (Hemodialysis and Peritoneal Dialysis), Product & Service (Equipment, Consumables, Drugs, and Services), and End User (In-center Dialysis and Home Dialysis): Global Opportunity Analysis and Industry Forecast, 2021-2028
出版日期: 2021年05月27日內容資訊: 英文 307 Pages
簡介

全球透析的市場規模在預測期間內預計將以4.7%的年複合成長率推移,從2020年的912億500萬美元,成長到2028年1297億5680萬美元的規模。

腎病增多、肥胖、糖尿病、高血壓、慢性病等生活習慣病、家庭血液透析傾向、大公司收購、聯盟、產品開發、技術創新等因素有望推動市場的增長。與此同時,預計新興國家透析治療相關並發症的增加和報銷挑戰將阻礙未來幾年的市場增長。

本報告提供全球透析的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,償付方案,市場規模的轉變·預測,類型·產品&服務·終端用戶·地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義·範圍
  • 主要調查結果
  • 波特的五力分析
  • 主要企業的地位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 償付方案
  • COVID-19:影響分析

第4章 市場分析·預測:各類型

  • 主要趨勢·成長機會
  • 市場規模·預測
  • 市場佔有率分析:各國
  • 血液透析機(HD)
    • 傳統血液透析機
    • 短時間頻回血液透析機
    • 夜間血液透析機
  • 腹膜透析(PD)
    • 持續可攜式腹膜透析(CAPD)
    • 自動腹膜透析(APD)

第5章 市場分析·預測:各類產品·服務

  • 主要趨勢·成長要素·成長機會
  • 市場規模·預測
  • 市場佔有率分析:各國
  • 設備
    • 透析設備
    • 水處理系統
    • 其他
  • 消耗品
    • 透析器
    • 導管
    • 其他
  • 透析藥
  • 服務

第6章 市場分析·預測:各終端用戶

  • 中心內透析
  • 家庭透析治療
    • 主要趨勢·成長機會
    • 市場規模·預測:各地區
    • 市場佔有率分析:各國

第7章 市場分析·預測:地區·各主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲
    • 主要趨勢·成長機會
    • 市場規模·預測:各國
    • 市場規模·預測:各類型
    • 市場規模·預測:產品&各類服務
    • 市場規模·預測:各終端用戶

第8章 企業簡介

  • FRESENIUS SE AND CO. KGAA
  • ASAHI KASEI CORPORATION
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON AND COMPANY(C. R. BARD, INC.)
  • DAVITA
  • ANGIODYNAMICS INC.
  • DIAVERUM DEUTSCHLAND GmbH.
  • NIKKISO CO. LTD.
  • NIPRO CORPORATION
目錄
Product Code: A00281

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys. The procedure is vital during the treatment of end-stage renal disease (ESRD) and chronic kidney disease (CKD). It can be performed in two ways, namely; hemodialysis and peritoneal dialysis. In hemodialysis (HD), a filter is used to remove the waste products and extra fluids from blood. The purified blood is then reintroduced into the patient's body. On the other hand, peritoneal dialysis (PD) is a treatment that uses the inner lining of abdomen, called peritoneum and a dialysis solution to clean and purify blood and reinstate it into the patient's body. Both hemodialysis and peritoneal dialysis work on a similar principle of purifying blood and removing toxins from the patient's body, when kidneys are unable to function normally.

The global dialysis market was valued at $91,205.0 million in 2020, and is estimated to reach $129,756.8 million by 2028, registering a CAGR of 4.7% from 2021 to 2028. This market growth is attributed to surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases such as obesity, diabetes, and hypertension are projected to further supplement the global dialysis market growth. Conversely, rise in complications related to dialysis treatment such as infections, hypotension, fluid overload, and access point bleeding are anticipated to obstruct the growth of the market in the coming years.

Similarly, reimbursement policy concerns in emerging nations impedes the growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach and surge in market strategies such as acquisitions, partnerships, product development, and innovation by key players are expected to offer profitable opportunities for the growth of the market during the forecast period.

The dialysis market is segmented on the basis of type, Product & Service, end user, and region. On the basis of type, it is bifurcated into hemodialysis and peritoneal dialysis. Hemodialysis is categorized into conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis. Peritoneal dialysis is further classified into continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD). On the basis of Product & Service, it is divided into equipment, consumables, drugs, and services. Equipment is further categorized into dialysis machines, water treatment systems, and others. Consumables are classified into dialyzers, catheters, and transfer sets. On the basis of end users, it is bifurcated into in-center dialysis and home dialysis. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2021 to 2028, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the dialysis market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Type

  • Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
  • Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

By Products and Services

  • Equipment
  • Dialysis Machines
  • Water Treatment Systems
  • Others Dialysis Equipment
  • Consumables
  • Dialyzers
  • Catheters
  • Other Dialysis Consumables
  • Dialysis Drugs
  • Services

By End User

  • In-center Dialysis
  • Home Dialysis

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • Nipro Corporation
  • B Braun Melsungen Ag
  • Nikkiso Co., Ltd.
  • Becton, Dickinson And Company (C. R. Bard, Inc.)
  • Angiodynamics Inc.
  • Asahi Kasei Corp.
  • Davita
  • Diaverum Deutschland Gmbh.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits to the stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Surge in incidences of kidney diseases
      • 3.5.1.2.Issues associated with kidney transplants
      • 3.5.1.3.Rise in prevalence of lifestyle and chronic diseases
    • 3.5.2.Restraints
      • 3.5.2.1.Complications in dialysis treatment
      • 3.5.2.2.Reimbursement policy concerns in emerging nations
    • 3.5.3.Opportunities
      • 3.5.3.1.Shift in preference of patients for home hemodialysis
      • 3.5.3.2.Surge in market strategies by key players
  • 3.6.Reimbursement scenario for dialysis (per patient)
  • 3.7.COVID 19 Impact on the Market

CHAPTER 4:DIALYSIS MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Hemodialysis (HD)
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market share analysis, by country
      • 4.2.3.1.Conventional Hemodialysis
      • 4.2.3.1.1.Market size and forecast
      • 4.2.3.2.Short daily hemodialysis
      • 4.2.3.2.1.Market size and forecast
      • 4.2.3.3.Nocturnal hemodialysis
      • 4.2.3.3.1.Market size and forecast
  • 4.3.Peritoneal dialysis (PD)
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market share analysis, by country
      • 4.3.3.1.Continuous Ambulatory Peritoneal Dialysis (CAPD)
      • 4.3.3.1.1.Market size and forecast
      • 4.3.3.2.Automated Peritoneal Dialysis (APD)
      • 4.3.3.2.1.Market size and forecast

CHAPTER 5:DIALYSIS MARKET, BY PRODUCT AND SERVICES

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.EQUIPMENT
    • 5.2.1.Key market trends, growth factors, and opportunities
    • 5.2.2.Market size and forecast
    • 5.2.3.Market share analysis, by country
    • 5.2.4.Dialysis Machines
      • 5.2.4.1.Market size and forecast
    • 5.2.5.Water Treatment Systems
      • 5.2.5.1.Market size and forecast
    • 5.2.6.Others dialysis equipment
      • 5.2.6.1.Market size and forecast
  • 5.3.Consumables
    • 5.3.1.Key market trends, growth factors, and opportunities
    • 5.3.2.Market size and forecast
    • 5.3.3.Market share analysis, by country
    • 5.3.4.Dialyzers
      • 5.3.4.1.Market size and forecast
    • 5.3.5.Catheters
      • 5.3.5.1.Market size and forecast
    • 5.3.6.Other dialysis consumables
      • 5.3.6.1.Market size and forecast
  • 5.4.Dialysis Drugs
    • 5.4.1.Key market trends, growth factors, and opportunities
    • 5.4.2.Market size and forecast
    • 5.4.3.Market share analysis, by country
  • 5.5.Services
    • 5.5.1.Key market trends, growth factors, and opportunities
    • 5.5.2.Market size and forecast
    • 5.5.3.Market share analysis, by country

CHAPTER 6:DIALYSIS MARKET, BY END USERS

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.In-center dialysis
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.Market size and forecast, by region
    • 6.2.3.Market share analysis, by country
  • 6.3.Home dialysis
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Market size and forecast, by region
    • 6.3.3.Market share analysis, by country

CHAPTER 7:DIALYSIS MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends and opportunities
    • 7.2.2.Market size and forecast, by country
    • 7.2.3.Market size and forecast, by type
    • 7.2.4.Market size and forecast, by products and services
    • 7.2.5.Market size and forecast, by end user
    • 7.2.6.U.S.
      • 7.2.6.1.Market size and forecast, by type
      • 7.2.6.2.Market size and forecast, by products and services
      • 7.2.6.3.Market size and forecast, by end user
    • 7.2.7.Canada
      • 7.2.7.1.Market size and forecast, by type
      • 7.2.7.2.Market size and forecast, by products and services
      • 7.2.7.3.Market size and forecast, by end user
    • 7.2.8.Mexico
      • 7.2.8.1.Market size and forecast, by type
      • 7.2.8.2.Market size and forecast, by products and services
      • 7.2.8.3.Market size and forecast, by end user
  • 7.3.Europe
    • 7.3.1.Key market trends and opportunities
    • 7.3.2.Market size and forecast, by country
    • 7.3.3.Market size and forecast, by type
    • 7.3.4.Market size and forecast, by products and services
    • 7.3.5.Market size and forecast, by end user
    • 7.3.6.UK
      • 7.3.6.1.Market size and forecast, by type
      • 7.3.6.2.Market size and forecast, by products and services
      • 7.3.6.3.Market size and forecast, by end user
    • 7.3.7.France
      • 7.3.7.1.Market size and forecast, by type
      • 7.3.7.2.Market size and forecast, by products and services
      • 7.3.7.3.Market size and forecast, by end user
    • 7.3.8.Spain
      • 7.3.8.1.Market size and forecast, by type
      • 7.3.8.2.Market size and forecast, by products and services
      • 7.3.8.3.Market size and forecast, by end user
    • 7.3.9.Italy
      • 7.3.9.1.Market size and forecast, by type
      • 7.3.9.2.Market size and forecast, by products and services
      • 7.3.9.3.Market size and forecast, by end user
    • 7.3.10.Germany
      • 7.3.10.1.Market size and forecast, by type
      • 7.3.10.2.Market size and forecast, by products and services
      • 7.3.10.3.Market size and forecast, by end user
    • 7.3.11.Rest of Europe
      • 7.3.11.1.Market size and forecast, by type
      • 7.3.11.2.Market size and forecast, by products and services
      • 7.3.11.3.Market size and forecast, by end user
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends and opportunities
    • 7.4.2.Market size and forecast, by country
    • 7.4.3.Market size and forecast, by type
    • 7.4.4.Market size and forecast, by products and services
    • 7.4.5.Market size and forecast, by end user
    • 7.4.6.Japan
      • 7.4.6.1.Market size and forecast, by type
      • 7.4.6.2.Market size and forecast, by products and services
      • 7.4.6.3.Market size and forecast, by end user
    • 7.4.7.China
      • 7.4.7.1.Market size and forecast, by type
      • 7.4.7.2.Market size and forecast, by products and services
      • 7.4.7.3.Market size and forecast, by end user
    • 7.4.8.Australia
      • 7.4.8.1.Market size and forecast, by type
      • 7.4.8.2.Market size and forecast, by products and services
      • 7.4.8.3.Market size and forecast, by end user
    • 7.4.9.India
      • 7.4.9.1.Market size and forecast, by type
      • 7.4.9.2.Market size and forecast, by products and services
      • 7.4.9.3.Market size and forecast, by end user
    • 7.4.10.South Korea
      • 7.4.10.1.Market size and forecast, by type
      • 7.4.10.2.Market size and forecast, by products and services
      • 7.4.10.3.Market size and forecast, by end user
    • 7.4.11.Taiwan
      • 7.4.11.1.Market size and forecast, by type
      • 7.4.11.2.Market size and forecast, by products and services
      • 7.4.11.3.Market size and forecast, by end user
    • 7.4.12.Rest of Asia-Pacific
      • 7.4.12.1.Market size and forecast, by type
      • 7.4.12.2.Market size and forecast, by products and services
      • 7.4.12.3.Market size and forecast, by end user
  • 7.5.LAMEA
    • 7.5.1.Key market trends and opportunities
    • 7.5.2.Market size and forecast, by country
    • 7.5.3.Market size and forecast, by type
    • 7.5.4.Market size and forecast, by products and services
    • 7.5.5.Market size and forecast, by end user
    • 7.5.6.Brazil
      • 7.5.6.1.Market size and forecast, by type
      • 7.5.6.2.Market size and forecast, by products and services
      • 7.5.6.3.Market size and forecast, by end user
    • 7.5.7.Saudi Arabia
      • 7.5.7.1.Market size and forecast, by type
      • 7.5.7.2.Market size and forecast, by products and services
      • 7.5.7.3.Market size and forecast, by end user
    • 7.5.8.South Africa
      • 7.5.8.1.Market size and forecast, by type
      • 7.5.8.2.Market size and forecast, by products and services
      • 7.5.8.3.Market size and forecast, by end user
    • 7.5.9.Rest of LAMEA
      • 7.5.9.1.Market size and forecast, by type
      • 7.5.9.2.Market size and forecast, by products and services
      • 7.5.9.3.Market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

  • 8.1.FRESENIUS SE AND CO. KGAA
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Business performance
    • 8.1.6.Key strategic moves and developments
  • 8.2.ASAHI KASEI CORPORATION
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
    • 8.2.5.Business performance
    • 8.2.6.Key strategic moves and developments
  • 8.3.B. BRAUN MELSUNGEN AG
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.BAXTER INTERNATIONAL INC.
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Business performance
    • 8.4.6.Key strategic moves and developments
  • 8.5.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
    • 8.5.6.Key strategic moves and developments
  • 8.6.DAVITA
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
    • 8.6.6.Key strategic moves and developments
  • 8.7.ANGIODYNAMICS INC.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Business performance
    • 8.7.6.Key strategic moves and developments
  • 8.8.DIAVERUM DEUTSCHLAND GmbH.
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.NIKKISO CO. LTD.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
    • 8.9.6.Key strategic moves and developments
  • 8.10.NIPRO CORPORATION
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.SIDE EFFECTS OF DIALYSIS
  • TABLE 02.ACCESS FISTULA AND GRAFTS
  • TABLE 03.ACCESS CATHETERS
  • TABLE 04.DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 05.DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 06.DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 07.HEMODIALYSIS MARKET FOR CONVENTIONAL HEMODIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 08.HEMODIALYSIS MARKET FOR SHORT DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 09.HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 10.DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 11.PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 12.PERITONEAL DIALYSIS MARKET FOR AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 13.DIALYSIS MARKET, BY PRODUCT AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 14.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 15.DIALYSIS EQUIPMENT MARKET BY TYPE, BY REGION, 2020-2028 ($MILLION)
  • TABLE 16.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 17.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 18.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 19.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 20.DIALYSIS EQUIPMENT MARKET BY TYPE, BY REGION, 2020-2028 ($MILLION)
  • TABLE 21.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 22.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 23.DIALYSIS MARKET FOR DAILY DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 24.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 25.DIALYSIS MARKET FOR EQUIPMENT, BY REGION, 2020-2028 ($MILLION)
  • TABLE 26.DIALYSIS MARKET, BY DIALYSIS SITE, 2020-2028 ($MILLION)
  • TABLE 27.DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 28.DIALYSIS MARKET FOR HOME DIALYSIS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 29.DIALYSIS MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 30.NORTH AMERICA DIALYSIS MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 31.NORTH AMERICA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 32.NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 33.NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 34.NORTH AMERICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 35.NORTH AMERICA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 36.NORTH AMERICA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 37.NORTH AMERICA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 38.U.S. DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 39.U.S. HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 40.U.S. PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 41.U.S. DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 42.U.S. DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 43.U.S. DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 44.U.S. DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 45.CANADA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 46.CANADA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 47.CANADA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 48.CANADA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 49.CANADA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 50.CANADA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 51.CANADA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 52.CANADA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 53.CANADA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 54.CANADA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 55.CANADA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 56.CANADA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 57.CANADA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 58.CANADA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 59.EUROPE DIALYSIS MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 60.EUROPE DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 61.EUROPE HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 62.EUROPE PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 63.EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 64.EUROPE DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 65.EUROPE DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 66.EUROPE DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 67.UK DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 68.UK HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 69.UK PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 70.UK DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 71.UK DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 72.UK DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 73.UK DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 74.FRANCE DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 75.FRANCE HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 76.FRANCE PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 77.FRANCE DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 78.FRANCE DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 79.FRANCE DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 80.FRANCE DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 81.SPAIN DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 82.SPAIN HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 83.SPAIN PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 84.SPAIN DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 85.SPAIN DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 86.SPAIN DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 87.SPAIN DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 88.ITALY DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 89.ITALY HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 90.ITALY PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 91.ITALY DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 92.ITALY DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 93.ITALY DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 94.ITALY DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 95.GERMANY DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 96.GERMANY HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 97.GERMANY PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 98.GERMANY DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 99.GERMANY DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 100.GERMANY DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 101.GERMANY DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 102.REST OF EUROPE DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 103.REST OF EUROPE HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 104.REST OF EUROPE PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 105.REST OF EUROPE DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 106.REST OF EUROPE DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 107.REST OF EUROPE DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 108.REST OF EUROPE DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 109.ASIA-PACIFIC DIALYSIS MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 110.ASIA-PACIFIC DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 111.ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 112.ASIA-PACIFIC PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 113.ASIA-PACIFIC DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 114.ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 115.ASIA-PACIFIC DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 116.ASIA-PACIFIC DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 117.JAPAN DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 118.JAPAN HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 119.JAPAN PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 120.JAPAN DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 121.JAPAN DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 122.JAPAN DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 123.JAPAN DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 124.CHINA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 125.CHINA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 126.CHINA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 127.CHINA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 128.CHINA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 129.CHINA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 130.CHINA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 131.AUSTRALIA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 132.AUSTRALIA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 133.AUSTRALIA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 134.AUSTRALIA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 135.AUSTRALIA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 136.AUSTRALIA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 137.AUSTRALIA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 138.INDIA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 139.INDIA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 140.INDIA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 141.INDIA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 142.INDIA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 143.INDIA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 144.INDIA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 145.SOUTH KOREA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 146.SOUTH KOREA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 147.SOUTH KOREA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 148.SOUTH KOREA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 149.SOUTH KOREA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 150.SOUTH KOREA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 151.SOUTH KOREA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 152.TAIWAN DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 153.TAIWAN HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 154.TAIWAN PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 155.TAIWAN DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 156.TAIWAN DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 157.TAIWAN DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 158.TAIWAN DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 159.REST OF ASIA-PACIFIC DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 160.REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 161.REST OF ASIA-PACIFIC PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 162.REST OF ASIA-PACIFIC DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 163.REST OF ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 164.REST OF ASIA-PACIFIC DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 165.REST OF ASIA-PACIFIC DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 166.LAMEA DIALYSIS MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 167.LAMEA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 168.LAMEA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 169.LAMEA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 170.LAMEA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 171.LAMEA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 172.LAMEA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 173.LAMEA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 174.BRAZIL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 175.BRAZIL HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 176.BRAZIL PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 177.BRAZIL DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 178.BRAZIL DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 179.BRAZIL DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 180.BRAZIL DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 181.SAUDI ARABIA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 182.SAUDI ARABIA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 183.SAUDI ARABIA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 184.SAUDI ARABIA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 185.SAUDI ARABIA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 186.SAUDI ARABIA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 187.SAUDI ARABIA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 188.SOUTH AFRICA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 189.SOUTH AFRICA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 190.SOUTH AFRICA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 191.SOUTH AFRICA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 192.SOUTH AFRICA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 193.SOUTH AFRICA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 194.SOUTH AFRICA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 195.REST OF LAMEA DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 196.REST OF LAMEA HEMODIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 197.REST OF LAMEA PERITONEAL DIALYSIS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 198.REST OF LAMEA DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2020-2028 ($MILLION)
  • TABLE 199.REST OF LAMEA DIALYSIS EQUIPMENT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 200.REST OF LAMEA DIALYSIS CONSUMABLE MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 201.REST OF LAMEA DIALYSIS MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 202.FRESENIUS: COMPANY SNAPSHOT
  • TABLE 203.FRESENIUS: OPERATING SEGMENTS
  • TABLE 204.FRESENIUS: PRODUCT PORTFOLIO
  • TABLE 205.FRESENIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 206.ASAHI KASEI: COMPANY SNAPSHOT
  • TABLE 207.ASAHI KASEI: OPERATING SEGMENTS
  • TABLE 208.ASAHI KASEI: PRODUCT PORTFOLIO
  • TABLE 209.ASAHI KASEI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 210.B. BRAUN: COMPANY SNAPSHOT
  • TABLE 211.B. BRAUN: OPERATING SEGMENTS
  • TABLE 212.B. BRAUN: PRODUCT PORTFOLIO
  • TABLE 213.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 214.BAXTER: COMPANY SNAPSHOT
  • TABLE 215.BAXTER: OPERATING SEGMENTS
  • TABLE 216.BAXTER: PRODUCT PORTFOLIO
  • TABLE 217.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 218.BD: COMPANY SNAPSHOT
  • TABLE 219.BD: OPERATING SEGMENTS
  • TABLE 220.BD: PRODUCT PORTFOLIO
  • TABLE 221.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 222.DAVITA: COMPANY SNAPSHOT
  • TABLE 223.DAVITA: OPERATING SEGMENTS
  • TABLE 224.DAVITA: PRODUCT PORTFOLIO
  • TABLE 225.DAVITA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 226.ANGIODYNAMICS: COMPANY SNAPSHOT
  • TABLE 227.ANGIODYNAMICS: PRODUCT SEGMENTS
  • TABLE 228.ANGIODYNAMICS: PRODUCT PORTFOLIO
  • TABLE 229.ANGIODYNAMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 230.DIAVERUM DEUTSCHLAND GMBH.: COMPANY SNAPSHOT
  • TABLE 231.DIAVERUM DEUTSCHLAND GMBH.: OPERATING SEGMENTS
  • TABLE 232.DIAVERUM DEUTSCHLAND GMBH.: PRODUCT PORTFOLIO
  • TABLE 233.DIAVERUM DEUTSCHLAND GMBH.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 234.NIKKISO: COMPANY SNAPSHOT
  • TABLE 235.NIKKISO: OPERATING SEGMENTS
  • TABLE 236.NIKKISO: PRODUCT PORTFOLIO
  • TABLE 237.NIKKISO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 238.NIPRO: COMPANY SNAPSHOT
  • TABLE 239.NIPRO: OPERATING SEGMENTS
  • TABLE 240.NIPRO: PRODUCT PORTFOLIO
  • TABLE 241.NIPRO: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

LIST OF FIGURE

  • FIGURE 01.SEGMENTATION OF DIALYSIS MARKET
  • FIGURE 02.TOP INVESTMENT POCKETS IN DIALYSIS MARKET
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020 (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020
  • FIGURE 06.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 09.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 10.HIGH COMPETITIVE RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.RESTRAINTS AND DRIVERS: DIALYSIS MARKET
  • FIGURE 13.PROJECTED PREVALENCE OF CKD IN 2020 AND 2030 IN ADULTS AGED 30 YEARS OR OLDER (U.S.)
  • FIGURE 14.PREVALENCE OF DIABETES IN POPULATION (MILLIONS) AND DIABETES PREVALENCE (%)
  • FIGURE 15.DIALYSIS REIMBURSEMENT SCENARIO AROUND THE WORLD
  • FIGURE 16.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR HEMODIALYSIS SEGMENT, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 17.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR PERITONEAL DIALYSIS SEGMENT, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 18.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 19.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 24.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 25.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR DAILY DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 26.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 27.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR CONVENTIONAL DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 28.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 29.COMPARATIVE ANALYSIS OF DIALYSIS MARKET FOR HOME DIALYSIS, BY COUNTRY, 2020 & 2028 (%)
  • FIGURE 30.GLOBAL PREVALENCE OF DIALYSIS, RATE PER MILLION POPULATION (PMP), AGE ≥ 18 YEARS
  • FIGURE 31.TRENDS IN ANNUAL NUMBER OF ESRD INCIDENT CASES AND STANDARD INCIDENCES RATES PER MILLION EACH YEAR, U.S.
  • FIGURE 32.FRESENIUS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 33.FRESENIUS: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 34.FRESENIUS: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 35.ASAHI KASEI: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 36.ASAHI KASEI: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 37.ASAHI KASEI: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 38.B. BRAUN: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 39.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 40.B. BRAUN: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 41.BAXTER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 42.BAXTER: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 43.BAXTER: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 44.BD: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 45.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 46.BD: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 47.DAVITA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 48.DAVITA: REVENUE SHARE, BY SEGMENTS, 2020 (%)
  • FIGURE 49.DAVITA: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 50.ANGIODYNAMICS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 51.ANGIODYNAMICS: REVENUE SHARE, BY SEGMENTS, 2020 (%)
  • FIGURE 52.ANGIODYNAMICS: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 53.DIAVERUM DEUTSCHLAND GMBH.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 54.DIAVERUM DEUTSCHLAND GMBH.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 55.DIAVERUM DEUTSCHLAND GMBH.: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 56.NIKKISO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 57.NIKKISO: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 58.NIKKISO: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 59.NIPRO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 60.NIPRO: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 61.NIPRO: REVENUE SHARE, BY REGION, 2020 (%)